Zain Khalpey, M.D.

Director, Artificial Heart & ECMO Program, Banner University

“Precision screening tools such as metabolomics, proteomics and genomics we can predict and treat heart failure before it even begins.”

Leslie Cho

Director, Women’s Cardiovascular Center, Cleveland Clinic

“There is a class of medications currently in development that has the potential for patients to only take cholesterol medication once or twice a year.”

Gerald Fletcher

Cardiologist, Professor, Mayo Clinic College of Medicine

“What we can do with catheterization and what we can do with valves is really changing things.”